Palisade Bio, Inc. Common Stock
$1.59
-$0.11 (-6.47%)
$1.58Day Range$1.72
Key Statistics
Market Cap
$296.26M
Shares Outstanding
174.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 28, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$1.68
Day High
$1.72
Day Low
$1.58
Volume
6.87M
VWAP
$1.61
Prev Close
$1.70
Transactions
--
Acc. Volume
--
About Palisade Bio, Inc. Common Stock
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283614 employees7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009(858) 704-4900IPO Apr 28, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001357459
- Composite FIGI
- BBG000QG4DJ2
- Share Class FIGI
- BBG001SS4KZ8
- Ticker Root
- PALI
- SIC Code
- 2836
About Palisade Bio, Inc. Common Stock (PALI) Stock
Palisade Bio, Inc. Common Stock (PALI) closed the 2026-09-18 session at $1.59, down 6.47% versus the previous close (-0.11). The stock opened at $1.68 and traded between $1.58 and $1.72 during that session. Session trading volume was 6.9M shares. The volume-weighted average price (VWAP) is $1.61.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Palisade Bio, Inc. Common Stock has a market capitalization of $296.3 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. PALI is listed on the XNAS exchange. The company employs approximately 14 people. Palisade Bio, Inc. Common Stock is headquartered in CARLSBAD, CA. The recorded listing date is 2021-04-28.
On this page you can find market PALI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.